190
Views
3
CrossRef citations to date
0
Altmetric
Women's Health

Graves’ disease could increase polycystic ovary syndrome and comorbidities in Taiwan

, , , , , & ORCID Icon show all
Pages 1063-1067 | Received 02 Jan 2020, Accepted 13 Apr 2020, Published online: 28 Apr 2020

References

  • Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375(16):1552–1565.
  • Barnett PS, McGregor AM. Immunological factors. Disease of the thyroid: pathophysiology and management. In: Wheeler MH, Lazarus JH, editors. Cambridge (UK): Chapman & Hall Medical; 1994. p. 85–103.
  • Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol Mech Dis. 2014;9(1):147–156.
  • Brix TH, Kyvik KO, Christensen K, et al. Evidence for a major role of heredity in Graves’ disease: a population based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86(2):930–934.
  • Kahaly GJ, Petrak F, Hardt J, et al. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrinol. 2005;63(4):395–402.
  • Brandt F, Almind D, Christensen K, et al. Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a Danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab. 2012;97(11):4123–4129.
  • Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286–295.
  • Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves’ disease. Trend Endocrinol Metab. 2005;16(5):243–248.
  • Subekti I. Diagnosis Dan Pengelolaan Oftalmopati Graves. Jakarta Endocrinology Meeting, Divisi Metabolik Endokrinologi, Departemen Ilmu Penyakit Dalam FKUI/RSCM, Jakarta; 2008. p. 30–35.
  • Koutras DA. Disturbances of menstruation in thyroid disease. Ann NY Acad Sci. 1997;816(1 Adolescent Gy):280–284.
  • Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–1236.
  • Homburg R. Polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2008;22(2):261–274.
  • Sen A, Kushnir VA, Barad DH, et al. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014;10(1):37–50.
  • van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38(5):381–386.
  • Hefler-Frischmuth K, Walch K, Huebl W, et al. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2010;93(7):2291–2294.
  • McGrogan A, Seaman HE, Wright JW, et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf). 2008;69(5):687–696.
  • Glintborg D, Rubin KH, Nybo M, et al. Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study. Endocr Connect. 2019;8(10):1405–1415.
  • Goi R, Matsuda M, Maekawa H, et al. Two cases of Hashimoto’s thyroiditis with transient hypothyroidism. Intern Med. 1992;31(1):64–68.
  • Jung JH, Hahm JR, Jung TS, et al. A 27-year-old woman diagnosed as polycystic ovary syndrome associated with Graves’ disease. Intern Med. 2011;50(19):2185–2189.
  • Tong C, Wang Y-H, Yu H-C, et al. Increased risk of polycystic ovary syndrome in Taiwanese women with chronic periodontitis: a nationwide population-based retrospective cohort study. J Womens Health. 2019;28(10):1436–1441.
  • Tellez M, Cooper J, Edmonds C. Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol. 1992;36(3):291–294.
  • Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363–369.
  • Takasu N, Yamada T, Sato A, et al. Graves’ disease following hypothyroidism due to Hashimoto’s disease: studies of eight cases. Clin Endocrinol (Oxf). 1990;33(6):687–698.
  • Krassas GE, Pontikides N, Kaltsas T, et al. Menstrual disturbances in thyrotoxicosis. Clin Endocrinol. 1994;40(5):641–644.
  • Redmond GP. Thyroid dysfunction and women’s reproductive health. Thyroid. 2004;14(supplement 1):S5–S15.
  • Reimand K, Talja I, Metskula K, et al. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol. 2001;51(2):167–176.
  • Nisar S, Shah PA, Shafi Kuchay M, et al. Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab. 2012;16(6):982.
  • Szczuko M, Zapałowska-Chwyc’ M, Drozd A, et al. Effect of IGF-I and TNF-a on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-a. Gynecol Endocrinol. 2016;32(9):714–717.
  • Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010;41(1):173–176.
  • Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
  • Lua ACY, How CH, King TFJ. Managing polycystic ovary syndrome in primary care. SMEDJ. 2018;59(11):567–571.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.